Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

JCO Early Release, published online ahead of print Oct 29 2007
Journal of Clinical Oncology, 10.1200/JCO.2007.14.1283

This Article
Right arrow Full Text (PDF)
Right arrow Publisher's Note
Right arrow Journal of Oncology Practice Summary
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lyman, G. H.
Right arrow Articles by Francis, C. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lyman, G. H.
Right arrow Articles by Francis, C. W.
Related Articles
Right arrowRelated Correspondence
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Received August 27, 2007
Accepted September 10, 2007

American Society of Clinical Oncology Guideline: Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer

Gary H. Lyman, Alok A. Khorana, Anna Falanga, Daniel Clarke-Pearson, Christopher Flowers, Mohammad Jahanzeb, Ajay Kakkar, Nicole M. Kuderer, Mark N. Levine, Howard Liebman, David Mendelson, Gary Raskob, Mark R. Somerfield, Paul Thodiyil, David Trent, and Charles W. Francis

From the Duke University Medical Center, University of Rochester Medical Center, Rochester; Ospedali Riuiniti Bergamo, Italy; University of North Carolina, NC; Winship Cancer Institute; University of Tennessee; Barts and The London School of Medicine; Thrombosis Research Institute; Duke University Medical Center, NC; McMaster University; University of Southern California; Premiere Oncology; University of Oklahoma Health Sciences Center; American Society of Clinical Oncology, Alexandria, VA; New York Methodist Hospital; and Veterans Administration Cancer Center.

Purpose: To develop guideline recommendations for the use of anticoagulation in the prevention and treatment of venous thromboembolism (VTE) in patients with cancer.

Methods: A comprehensive systematic review of the medical literature on the prevention and treatment of VTE in cancer patients was conducted and reviewed by a panel of content and methodology experts. Following discussion of the results, the panel drafted recommendations for the use of anticoagulation in patients with malignant disease.

Results: The results of randomized controlled trials of primary and secondary VTE medical prophylaxis, surgical prophylaxis, VTE treatment, and the impact of anticoagulation on survival of patients with cancer were reviewed. Recommendations were developed on the prevention of VTE in hospitalized, ambulatory, and surgical cancer patients as well as patients with established VTE, and for use of anticoagulants in cancer patients without VTE to improve survival.

Conclusion: Recommendations of the American Society of Clinical Oncology VTE Guideline Panel include (1) all hospitalized cancer patients should be considered for VTE prophylaxis with anticoagulants in the absence of bleeding or other contraindications; (2) routine prophylaxis of ambulatory cancer patients with anticoagulation is not recommended, with the exception of patients receiving thalidomide or lenalidomide; (3) patients undergoing major surgery for malignant disease should be considered for pharmacologic thromboprophylaxis; (4) low molecular weight heparin represents the preferred agent for both the initial and continuing treatment of cancer patients with established VTE; and (5) the impact of anticoagulants on cancer patient survival requires additional study and cannot be recommended at present.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Related Correspondence

  • Treatment of Venous Thrombosis in Patients With Intracranial Malignancies
    Carl D. Atkins
    JCO 2008 26: 1905 [Full Text]
  • Low Platelet Counts in Cancer Patients: Should Heparin for Venous Thromboembolism Prophylaxis Be Instituted?
    Nishith K. Singh and Gaurav Sangwan
    JCO 2008 26: 1906 [Full Text]


This article has been cited by other articles:


Home page
 Ann OncolHome page
M. Mandala, A. Falanga, and R. Labianca
Video meliora proboque sed deteriora sequor: the case of thromboprophylaxis in hospitalized cancer patients
Ann. Onc., November 4, 2009; (2009) mdp500v1.
[Full Text] [PDF]

Home page
 Ann OncolHome page
N. Kucher, D. Spirk, I. Baumgartner, L. Mazzolai, W. Korte, D. Nobel, M. Banyai, and H. Bounameaux
Lack of prophylaxis before the onset of acute venous thromboembolism among hospitalized cancer patients: the SWIss Venous ThromboEmbolism Registry (SWIVTER)
Ann. Onc., October 14, 2009; (2009) mdp406v1.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
C. W. Francis
Prevention of Venous Thromboembolism in Hospitalized Patients With Cancer
J. Clin. Oncol., October 10, 2009; 27(29): 4874 - 4880.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. A. Khorana, M. B. Streiff, D. Farge, M. Mandala, P. Debourdeau, F. Cajfinger, M. Marty, A. Falanga, and G. H. Lyman
Venous Thromboembolism Prophylaxis and Treatment in Cancer: A Consensus Statement of Major Guidelines Panels and Call to Action
J. Clin. Oncol., October 10, 2009; 27(29): 4919 - 4926.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. Y.Y. Lee
Anticoagulation in the Treatment of Established Venous Thromboembolism in Patients With Cancer
J. Clin. Oncol., October 10, 2009; 27(29): 4895 - 4901.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. K. Kakkar
Prevention of Venous Thromboembolism in the Cancer Surgical Patient
J. Clin. Oncol., October 10, 2009; 27(29): 4881 - 4884.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
M. B. Streiff
Diagnosis and Initial Treatment of Venous Thromboembolism in Patients With Cancer
J. Clin. Oncol., October 10, 2009; 27(29): 4889 - 4894.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
G. H. Lyman and A. A. Khorana
Cancer, Clots and Consensus: New Understanding of an Old Problem
J. Clin. Oncol., October 10, 2009; 27(29): 4821 - 4826.
[Full Text] [PDF]

Home page
 JCOHome page
A. Falanga and M. Marchetti
Venous Thromboembolism in the Hematologic Malignancies
J. Clin. Oncol., October 10, 2009; 27(29): 4848 - 4857.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
P. Rana and M. N. Levine
Prevention of Thrombosis in Ambulatory Patients With Cancer
J. Clin. Oncol., October 10, 2009; 27(29): 4885 - 4888.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
A. Patel, M. Anraku, G. E. Darling, F. A. Shepherd, A. F. Pierre, T. K. Waddell, S. Keshavjee, and M. de Perrot
Venous thromboembolism in patients receiving multimodality therapy for thoracic malignancies
J. Thorac. Cardiovasc. Surg., October 1, 2009; 138(4): 843 - 848.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
A. A. Khorana
Cancer and thrombosis: implications of published guidelines for clinical practice
Ann. Onc., October 1, 2009; 20(10): 1619 - 1630.
[Abstract] [Full Text] [PDF]

Home page
 Anticancer ResHome page
E. PAN, J. S. TSAI, and S. B. MITCHELL
Retrospective Study of Venous Thromboembolic and Intracerebral Hemorrhagic Events in Glioblastoma Patients
Anticancer Res, October 1, 2009; 29(10): 4309 - 4313.
[Abstract] [Full Text] [PDF]

Home page
 J Oncol Pharm PractHome page
A. C Fullmer and R. Miller
Retrospective review of hemoglobin and/or hematocrit levels with occurrence of thrombosis in cancer patients treated with erythropoiesis stimulating agents
Journal of Oncology Pharmacy Practice, September 1, 2009; 15(3): 167 - 173.
[Abstract] [PDF]

Home page
 Ann OncolHome page
M. Mandala, S. Barni, M. Prins, R. Labianca, C. Tondini, L. Russo, A. Milesi, M. Cremonesi, M. Zaccanelli, C. Regonesi, et al.
Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: a prospective trial
Ann. Onc., August 27, 2009; (2009) mdp354v1.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
N. Starling, S. Rao, D. Cunningham, T. Iveson, M. Nicolson, F. Coxon, G. Middleton, F. Daniel, J. Oates, and A. R. Norman
Thromboembolism in Patients With Advanced Gastroesophageal Cancer Treated With Anthracycline, Platinum, and Fluoropyrimidine Combination Chemotherapy: A Report From the UK National Cancer Research Institute Upper Gastrointestinal Clinical Studies Group
J. Clin. Oncol., August 10, 2009; 27(23): 3786 - 3793.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. M. Tsimberidou, L. H. Camacho, S. Verstovsek, C. Ng, D. S. Hong, C. K. Uehara, C. Gutierrez, S. Daring, J. Stevens, P. B. Komarnitsky, et al.
A Phase I Clinical Trial of Darinaparsin in Patients with Refractory Solid Tumors
Clin. Cancer Res., July 15, 2009; 15(14): 4769 - 4776.
[Abstract] [Full Text] [PDF]

Home page
 J Oncol PractHome page
A. N. Amin, J. Lin, G. Yang, and S. Stemkowski
Are There Any Differences in the Clinical and Economic Outcomes Between US Cancer Patients Receiving Appropriate or Inappropriate Venous Thromboembolism Prophylaxis?
J. Oncol. Pract, July 1, 2009; 5(4): 159 - 164.
[Abstract] [Full Text] [PDF]

Home page
 J Oncol PractHome page
G. H Lyman
Preventing Venous Thromboembolism in Cancer Patients: Can We Do Better?
J. Oncol. Pract, July 1, 2009; 5(4): 165 - 166.
[Full Text] [PDF]

Home page
 Ann OncolHome page
M. Mandala, A. Falanga, F. Roila, and On behalf of the ESMO Guidelines Working Group
Management of venous thromboembolism in cancer patients: ESMO Clinical Recommendations
Ann. Onc., May 1, 2009; 20(suppl_4): iv182 - iv184.
[Full Text] [PDF]

Home page
 BMJ Case ReportsHome page
S. Verma and R. Garg
Report on a patient with pre-existing venous thrombosis and incidental malignancy undergoing urgent laparotomy: preoperative concerns
BMJ Case Reports, March 5, 2009; 2009(mar05_1): bcr1020081029 - bcr1020081029.
[Abstract] [Full Text]

Home page
 Cleveland Clinic Journal of MedicineHome page
D. MICKELSON, E. N. MADY, and K. TENG
A 43-year-old woman with chest pressure
Cleveland Clinic Journal of Medicine, March 1, 2009; 76(3): 191 - 198.
[Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
T. Sousou and A. A. Khorana
New Insights Into Cancer-Associated Thrombosis
Arterioscler Thromb Vasc Biol, March 1, 2009; 29(3): 316 - 320.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
P. Rana, J. Julian, and M. Levine
P-selectin ready for prime time?
Blood, February 19, 2009; 113(8): 1860 - 1860.
[Full Text] [PDF]

Home page
 Am Soc Clin Oncol Ed BookHome page
A. A. Khorana and G. H. Lyman
Incidence and Prevention of Cancer-associated Thrombosis
ASCO Educational Book, January 1, 2009; 2009(1): 321 - 325.
[Abstract] [Full Text] [PDF]

Home page
 Am Soc Clin Oncol Ed BookHome page
A. Y.Y. Lee
Treatment of Venous Thromboembolism in Patients with Cancer
ASCO Educational Book, January 1, 2009; 2009(1): 331 - 336.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
S. R. Nalluri, D. Chu, R. Keresztes, X. Zhu, and S. Wu
Risk of Venous Thromboembolism With the Angiogenesis Inhibitor Bevacizumab in Cancer Patients: A Meta-analysis
JAMA, November 19, 2008; 300(19): 2277 - 2285.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
M. Carrier, G. Le Gal, P. S. Wells, D. Fergusson, T. Ramsay, and M. A. Rodger
Systematic Review: The Trousseau Syndrome Revisited: Should We Screen Extensively for Cancer in Patients with Venous Thromboembolism?
Ann Intern Med, September 2, 2008; 149(5): 323 - 333.
[Abstract] [Full Text] [PDF]

Home page
 haematolHome page
P. Prandoni, J. Trujillo-Santos, T. Surico, F. D. Valle, A. Piccioli, M. Monreal, and for the RIETE Investigators
Recurrent thromboembolism and major bleeding during oral anticoagulant therapy in patients with solid cancer: findings from the RIETE registry
Haematologica, September 1, 2008; 93(9): 1432 - 1434.
[Full Text] [PDF]

Home page
 ChestHome page
J. F. Collen, J. L. Jackson, A. F. Shorr, and L. K. Moores
Prevention of Venous Thromboembolism in Neurosurgery: A Metaanalysis
Chest, August 1, 2008; 134(2): 237 - 249.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
D. E. Gerber, J. B. Segal, M. Y. Levy, J. Kane, R. J. Jones, and M. B. Streiff
The incidence of and risk factors for venous thromboembolism (VTE) and bleeding among 1514 patients undergoing hematopoietic stem cell transplantation: implications for VTE prevention
Blood, August 1, 2008; 112(3): 504 - 510.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
M. Dicato
Venous Thromboembolic Events and Erythropoiesis-Stimulating Agents: An Update
Oncologist, May 1, 2008; 13(suppl_3): 11 - 15.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
C. D. Atkins
Treatment of Venous Thrombosis in Patients With Intracranial Malignancies
J. Clin. Oncol., April 10, 2008; 26(11): 1905 - 1905.
[Full Text] [PDF]

Home page
 JCOHome page
A. A. Khorana, C. W. Francis, A. Falanga, and G. H. Lyman
In Reply
J. Clin. Oncol., April 10, 2008; 26(11): 1906 - 1907.
[Full Text] [PDF]

Home page
 JCOHome page
N. K. Singh and G. Sangwan
Low Platelet Counts in Cancer Patients: Should Heparin for Venous Thromboembolism Prophylaxis Be Instituted?
J. Clin. Oncol., April 10, 2008; 26(11): 1906 - 1906.
[Full Text] [PDF]

Home page
 Journal of Pharmacy PracticeHome page
E. N. Brown and J. D. Herrington
Review of the Relationship Between Venous Thromboembolism, Malignancy and Its Treatment
Journal of Pharmacy Practice, April 1, 2008; 21(2): 126 - 137.
[Abstract] [PDF]

Home page
 Am Soc Clin Oncol Ed BookHome page
A. A. Khorana, H. A. Liebman, R. H. White, T. Wun, and G. H. Lyman
The Risk of Venous Thromboembolism in Patients with Cancer
ASCO Educational Book, January 1, 2008; 2008(1): 240 - 248.
[Abstract] [Full Text] [PDF]

Home page
 Am Soc Clin Oncol Ed BookHome page
C. W. Francis, A. K. Kakkar, M. N. Levine, and G. H. Lyman
Prevention of Venous Thromboembolism in Patients with Cancer
ASCO Educational Book, January 1, 2008; 2008(1): 250 - 256.
[Abstract] [Full Text] [PDF]

Home page
 Am Soc Clin Oncol Ed BookHome page
A. Falanga, A. Y. Y. Lee, M. B. Streiff, and G. H. Lyman
Anticoagulation in the Treatment of Venous Thromboembolism in Patients with Cancer
ASCO Educational Book, January 1, 2008; 2008(1): 258 - 268.
[Abstract] [Full Text] [PDF]


About
JCO		 Editorial
Roster		 Advertising
Information		 Librarians &
Institutions		 Rights &
Permissions		 PDA Services

Copyright © 2007 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online